ASTRAZENECA PHARMA INDIA
|
ASTRAZENECA PHARMA INDIA Last 5 Year Balance Sheet History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr |
| Equity - Authorised | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr |
| Equity - Issued | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr |
| Equity Paid Up | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr | ₹5.00 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 |
| Share Warrants & Outstandings | ₹7.15 Cr | ₹3.29 Cr | ₹2.57 Cr | ₹1.95 Cr | ₹1.59 Cr |
| Total Reserves | ₹758 Cr | ₹704 Cr | ₹581 Cr | ₹504 Cr | ₹450 Cr |
| Securities Premium | - | - | - | - | - |
| Capital Reserves | ₹72 Cr | ₹72 Cr | ₹72 Cr | ₹72 Cr | ₹72 Cr |
| Profit & Loss Account Balance | ₹633 Cr | ₹578 Cr | ₹456 Cr | ₹379 Cr | ₹324 Cr |
| General Reserves | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr |
| Other Reserves | - | - | - | - | - |
| Reserve excluding Revaluation Reserve | ₹758 Cr | ₹704 Cr | ₹581 Cr | ₹504 Cr | ₹450 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹770 Cr | ₹712 Cr | ₹589 Cr | ₹511 Cr | ₹456 Cr |
| Minority Interest | - | - | - | - | - |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | - | - | - | - | - |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | - | - | - | - | - |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | - | - | - | - | - |
| Unsecured Loans | - | - | - | - | - |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹-42 Cr | ₹-21 Cr | ₹-21 Cr | ₹-16 Cr | ₹-15 Cr |
| Deferred Tax Assets | ₹51 Cr | ₹22 Cr | ₹22 Cr | ₹18 Cr | ₹17 Cr |
| Deferred Tax Liability | ₹8.98 Cr | ₹1.06 Cr | ₹1.53 Cr | ₹1.87 Cr | ₹2.78 Cr |
| Other Long Term Liabilities | ₹38 Cr | ₹2.78 Cr | ₹3.69 Cr | ₹5.02 Cr | ₹8.63 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹162 Cr | ₹116 Cr | ₹86 Cr | ₹85 Cr | ₹51 Cr |
| Total Non-Current Liabilities | ₹159 Cr | ₹98 Cr | ₹69 Cr | ₹74 Cr | ₹45 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹456 Cr | ₹197 Cr | ₹228 Cr | ₹190 Cr | ₹178 Cr |
| Sundry Creditors | ₹456 Cr | ₹197 Cr | ₹228 Cr | ₹190 Cr | ₹178 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹130 Cr | ₹111 Cr | ₹112 Cr | ₹94 Cr | ₹83 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹1.02 Cr | ₹0.56 Cr | ₹0.37 Cr | - | - |
| Interest Accrued But Not Due | - | - | - | - | - |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹129 Cr | ₹110 Cr | ₹112 Cr | ₹94 Cr | ₹83 Cr |
| Short Term Borrowings | - | - | - | - | - |
| Secured ST Loans repayable on Demands | - | - | - | - | - |
| Working Capital Loans- Sec | - | - | - | - | - |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | - | - | - | - | - |
| Short Term Provisions | ₹322 Cr | ₹160 Cr | ₹145 Cr | ₹108 Cr | ₹112 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹222 Cr | ₹121 Cr | ₹107 Cr | ₹69 Cr | ₹80 Cr |
| Provision for post retirement benefits | ₹0.38 Cr | ₹1.06 Cr | ₹0.63 Cr | ₹0.54 Cr | ₹0.50 Cr |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹100 Cr | ₹38 Cr | ₹37 Cr | ₹38 Cr | ₹32 Cr |
| Total Current Liabilities | ₹908 Cr | ₹467 Cr | ₹484 Cr | ₹392 Cr | ₹373 Cr |
| Total Liabilities | ₹1,838 Cr | ₹1,277 Cr | ₹1,142 Cr | ₹977 Cr | ₹874 Cr |
| ASSETS | |||||
| Gross Block | ₹218 Cr | ₹187 Cr | ₹179 Cr | ₹169 Cr | ₹160 Cr |
| Less: Accumulated Depreciation | ₹153 Cr | ₹120 Cr | ₹110 Cr | ₹94 Cr | ₹79 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹64 Cr | ₹67 Cr | ₹69 Cr | ₹74 Cr | ₹81 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | - | ₹0.27 Cr | ₹1.33 Cr | ₹2.20 Cr | ₹4.02 Cr |
| Non Current Investments | - | - | - | - | - |
| Long Term Investment | - | - | - | - | - |
| Quoted | - | - | - | - | - |
| Unquoted | - | - | - | - | - |
| Long Term Loans & Advances | ₹222 Cr | ₹167 Cr | ₹136 Cr | ₹135 Cr | ₹101 Cr |
| Other Non Current Assets | ₹3.65 Cr | - | - | - | ₹0.01 Cr |
| Total Non-Current Assets | ₹290 Cr | ₹234 Cr | ₹206 Cr | ₹212 Cr | ₹186 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | - | - | - | - | - |
| Quoted | - | - | - | - | - |
| Unquoted | - | - | - | - | - |
| Inventories | ₹549 Cr | ₹228 Cr | ₹190 Cr | ₹140 Cr | ₹160 Cr |
| Raw Materials | ₹8.98 Cr | ₹18 Cr | ₹15 Cr | ₹14 Cr | ₹20 Cr |
| Work-in Progress | ₹6.77 Cr | ₹4.73 Cr | ₹1.67 Cr | ₹3.06 Cr | ₹3.74 Cr |
| Finished Goods | ₹145 Cr | ₹44 Cr | ₹37 Cr | ₹39 Cr | ₹33 Cr |
| Packing Materials | ₹0.99 Cr | ₹1.34 Cr | ₹1.51 Cr | ₹1.76 Cr | ₹2.14 Cr |
| Stores  and Spare | ₹1.55 Cr | ₹1.74 Cr | ₹1.72 Cr | ₹1.77 Cr | ₹1.78 Cr |
| Other Inventory | ₹385 Cr | ₹158 Cr | ₹133 Cr | ₹81 Cr | ₹100 Cr |
| Sundry Debtors | ₹185 Cr | ₹153 Cr | ₹108 Cr | ₹86 Cr | ₹85 Cr |
| Debtors more than Six months | ₹15 Cr | ₹15 Cr | ₹9.64 Cr | ₹10 Cr | ₹6.81 Cr |
| Debtors Others | ₹192 Cr | ₹160 Cr | ₹115 Cr | ₹91 Cr | ₹89 Cr |
| Cash and Bank | ₹537 Cr | ₹506 Cr | ₹500 Cr | ₹448 Cr | ₹352 Cr |
| Cash in hand | - | - | - | - | - |
| Balances at Bank | ₹537 Cr | ₹506 Cr | ₹500 Cr | ₹448 Cr | ₹352 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹16 Cr | ₹13 Cr | ₹14 Cr | ₹13 Cr | ₹9.84 Cr |
| Interest accrued on Investments | ₹1.99 Cr | ₹2.27 Cr | ₹1.79 Cr | ₹1.82 Cr | ₹1.45 Cr |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹14 Cr | ₹11 Cr | ₹12 Cr | ₹11 Cr | ₹8.39 Cr |
| Other current_assets | - | - | - | - | - |
| Short Term Loans and Advances | ₹261 Cr | ₹143 Cr | ₹124 Cr | ₹78 Cr | ₹82 Cr |
| Advances recoverable in cash or in kind | ₹5.29 Cr | ₹1.01 Cr | ₹0.65 Cr | ₹1.27 Cr | ₹0.55 Cr |
| Advance income tax and TDS | ₹205 Cr | ₹110 Cr | ₹100 Cr | ₹60 Cr | ₹70 Cr |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹51 Cr | ₹32 Cr | ₹23 Cr | ₹17 Cr | ₹11 Cr |
| Total Current Assets | ₹1,548 Cr | ₹1,043 Cr | ₹936 Cr | ₹765 Cr | ₹689 Cr |
| Net Current Assets (Including Current Investments) | ₹639 Cr | ₹576 Cr | ₹452 Cr | ₹373 Cr | ₹315 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹1,838 Cr | ₹1,277 Cr | ₹1,142 Cr | ₹977 Cr | ₹874 Cr |
| Contingent Liabilities | ₹98 Cr | ₹138 Cr | ₹132 Cr | ₹123 Cr | ₹86 Cr |
| Total Debt | - | - | - | - | - |
| Book Value | 305.28 | 283.45 | 234.45 | 203.78 | 181.83 |
| Adjusted Book Value | 305.28 | 283.45 | 234.45 | 203.78 | 181.83 |
Compare Balance Sheet of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹23,270.8 Cr | -0.4% | 5.7% | 29.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,471.0 Cr | 0.3% | 4.1% | -9.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,294.0 Cr | -1.7% | 8.5% | 13.2% | Stock Analytics | |
| CIPLA | ₹127,946.0 Cr | -3.4% | 3% | 4.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,691.0 Cr | 0.7% | -0.5% | 7.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,214.0 Cr | 0.2% | -1.1% | -3.6% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | -0.4% |
5.7% |
29.3% |
| SENSEX | 1% |
3.3% |
4.5% |
You may also like the below Video Courses